LENZ Therapeutics (LENZ) Change in Acquisitions & Divestments (2022 - 2026)

LENZ Therapeutics (LENZ) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $49.2 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 5.48% year-over-year to $49.2 million in Q1 2026; TTM through Mar 2026 was $203.1 million, a 66.49% increase from a year earlier, with the FY2025 full-year figure at $206.0 million, up 134.31% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $49.2 million, up from $43.3 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for LENZ reached as high as $90.0 million in Q3 2022 and fell as low as $1.5 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $41.2 million across 5 years, with a median of $43.3 million in 2025.
• Across the five-year window, Change in Acquisitions & Divestments slumped 98.33% in 2023 and soared 1366.67% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $80.2 million in 2022, then tumbled by 73.83% to $21.0 million in 2023, then surged by 66.19% to $34.9 million in 2024, then grew by 24.18% to $43.3 million in 2025, then increased by 13.6% to $49.2 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $49.2 million in Q1 2026, $43.3 million in Q4 2025, and $52.4 million in Q3 2025.